Landmark Trial Begins: Allegations Rise Over Truvada’s Safety and Disclosure Practices
San Francisco, CA – A groundbreaking legal battle is underway in San Francisco where a group of plaintiffs has filed a lawsuit against Gilead Sciences Inc., the manufacturer of Truvada, a drug widely used in the treatment and prevention of HIV. The lawsuit alleges that Gilead held back on a safer alternative to Truvada for years to maximize profits from its existing patent, deliberately compromising patient safety. Truvada, known generically as emtricitabine/tenofovir disoproxil fumarate, has been instrumental in both HIV treatment and as a pre-exposure prophylaxis (PrEP) that reduces the risk of HIV infection. However, … Read more